The expression patterns of CD44, HAS1 and MMP9 in ccRCC-TT exhibited a similar expression tendency, indicating that the CD44/HAS1/MMP9 regulatory system may have a significant impact on the aggressiveness of ccRCC. The gene discussed is CD44; the disease is nonpapillary renal cell carcinoma.